A benefit/risk analysis of the promethium-147-fueled pacemaker battery has been presented. Benefits are based principally on its expected lifetime of 7 to 9 years in a pacemaker. This fact reduces, for the patient, risks of the effects of battery depletion and risks of the complications of reimplantation operations. The increased battery life also decreases costs.
CITATION STYLE
Franco, R., & Smith, M. L. (1975). Benefits and Risks of Promethium Battery-Powered Pacemakers. In Engineering in Medicine (pp. 539–550). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-66187-7_33
Mendeley helps you to discover research relevant for your work.